Subscribe to The Latest from LDI
This Week at LDI
September 15, 2020
Time to Change FDA Restrictions on Mifepristone?
Recent studies from Courtney Schreiber and colleagues point to the clinical and cost effectiveness of mifepristone for the medical management of first trimester miscarriage, and call into question restrictive FDA regulations on access to the drug.
Previous Issues
LDI Insight
August 27, 2020
Characteristics of Nursing Homes with COVID-19 Cases
In JAMA Network Open, Paula Chatterjee and Rachel Werner compare nursing homes with and without COVID-19 cases. The biggest difference between the two groups was in the county-level case rates of COVID-19, suggesting that when the surrounding population case rate is high, area nursing homes are at a high risk of infections.